Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2020 Q1 earnings Read more ...
Vir and Alnylam Go Ahead with COVID-19 Gene Silencing Therapy Vir Biotechnology ( VIR ) announced a new COVID-19 drug candidate, VIR-2703. The company is collaborating with Alnylam Pharmaceuticals ( ALNY ) for developing this treatment which is an inhalable RNAi therapeutic which works by ...
Musings Unless you are solely invested in Technology stocks, your portfolio is likely nothing but a sea of red this year (despite a bump off the lows in April). Basically everything is hurting (no shocker there), but that’s not what I’m focused on at the moment. I’m tryi...
Teva Receives Positive Ruling on Cancer Drug Patents Teva Pharmaceuticals Industries Ltd. ( TEVA ) received a boost as it received positive ruling on its Bendeka cancer drug. The ruling may ensure that the drug is not thwarted by generic competition in the market for a considerable period...
Introduction This is a time of uncertainty. In my latest update of my dividend growth portfolio, I addressed the challenges of investing during the time of Corona. Most of them are mentally, and I simply keep executing my plan. In times like these, I keep looking for a good risk and reward...
Market Pulse The COVID-19 pandemic has thrust biopharma to the forefront in the search for a solution. And biotechs will remain at the investing forefront as the quest for anti-viral treatments and vaccines continues to be the race for the holy grail that can restore economic activity around...
Amarin ( AMRN ) held a conference call yesterday after announcing earnings - this was the first in-depth call after the ANDA lawsuit fiasco, and investors were eager to hear what the CEO had to say. CEO John Thero began the call with a note that they did $150mn in global revenue in Q1, h...
Amarin, Corp ( AMRN ) has been an extremely turbulent and highly visible stock over the years, with investors making and losing fortunes on the volatility generated by the interim successes and failures of the company's cardiovascular therapy, Vascepa . To be sure, this drug developer has succ...
The threat of declining earnings because of reduced economic activity caused by the spread of the coronavirus, Covid-19, has finally overtaken the unbridled optimism that's been fueled by seasonal tailwinds , a resolution of impeachment worries, and decreasing trade tensions. As a result, o...
Quick Take NLS Pharmaceutics ( NLSP ) has filed to raise $40.25 million in an IPO of its common stock, according to an F-1 registration statement . The company is advancing a pipeline of drug candidates for the treatment of various central nervous system disorders. NLSP expects to begin...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: